Jupiter Hospital Deploys India’s First Healthcare Chiller Plant Optimiser by Johnson Controls India, Advancing Smart Hospital Infrastructure

IMT News Desk
IMT News Desk
· 3 min read
Jupiter Hospital Deploys India’s First Healthcare Chiller Plant Optimiser by Johnson Controls India, Advancing Smart Hospital Infrastructure

Jupiter Hospital has implemented India’s first healthcare deployment of Johnson Controls India’s Chiller Plant Optimiser (CPO), introducing artificial intelligence into a critical but often overlooked area of hospital infrastructure: cooling systems. The move marks a significant step toward smarter, more resilient hospital operations that prioritise both clinical safety and energy efficiency.

Cooling systems in hospitals do far more than provide comfort; they sustain the precise temperature, humidity and air quality required by operation theatres, ICUs, blood banks, pharmacies and imaging suites. Stable cooling is also vital for the reliable performance of sensitive diagnostic equipment such as MRI and CT scanners. Any interruption can disrupt clinical workflows, compromise medication storage and affect infection-control environments.

Heating, ventilation and air-conditioning (HVAC) systems account for 40- 60% of a hospital’s total energy consumption, with the chiller plant alone responsible for up to 35% of electricity use. To address this, the AI-driven CPO integrates and automatically controls the entire chiller ecosystem- chillers, primary pumps, condenser pumps and cooling towers- using real-time adaptive controls that continuously tune equipment performance to match cooling demand and ambient conditions.

Hospital cooling demand varies widely through the day, rising to 450–500 TR (tonnes of refrigeration) during peak hours and dropping to 220- 250 TR at night. Traditionally, plant performance matching has required frequent manual intervention. The CPO automates these adjustments, enabling the plant to operate at a claimed efficiency of 0.72- 0.75 kW/TR while maintaining precise environmental conditions.

The platform delivers real-time visibility into plant operations and power consumption, allowing engineering teams to monitor performance remotely, receive control updates and track operational changes instantly. Every optimisation decision made by the AI server generates notifications and control messages, providing transparency and traceability for maintenance and audit purposes.

Compared with conventional manual controls, Johnson Controls India’s Chiller Plant Optimiser is expected to reduce chiller plant energy consumption by 15- 20%. Jupiter Hospital estimates this will translate into an annual avoidance of approximately 127,500 kg of CO₂ emissions, supporting the hospital’s sustainability and ESG objectives.

“In a hospital environment, cooling isn’t a comfort system; it’s a clinical infrastructure,” said Neelesh Shinde, Group Chief Technical Officer & Head- Projects, Jupiter Hospital. “Patient safety, infection control and the performance of critical medical equipment depend on stable temperature and humidity conditions. The AI-driven Chiller Plant Optimiser enables real-time adaptive control across the cooling ecosystem, helping us maintain these conditions while improving energy efficiency and operational reliability.

Shinde added that the system continuously analyses plant behaviour, identifies performance deviations and enables faster corrective action. He noted that the CPO’s fully on-premises architecture keeps operational data within the hospital network, addressing cybersecurity concerns while delivering AI-driven optimisation. “As hospitals move toward smarter infrastructure, technologies such as predictive maintenance, digital twins and self-learning systems will play an increasingly important role in improving resilience and sustainability,” he said.

With climate-related events becoming more frequent and healthcare facilities facing rising energy demands, resilient infrastructure is increasingly a strategic priority. AI-enabled systems like the Chiller Plant Optimiser can help hospitals anticipate demand surges, optimise equipment usage and maintain uninterrupted operations during peak stress, delivering benefits for patient care, cost management and environmental impact.

Read Next

India’s first focused health AI Conclave unites doctors and AI experts
Featured Article
July 10, 2026

India’s first focused health AI Conclave unites doctors and AI experts

• Global Healthcare Academy hosts HAI Conclave 2026, India’s first national platform dedicated to Healthcare and Artificial Intelligence • Landmark Bengaluru conference brings together healthcare leaders and AI experts to explore how Artificial Intelligence can make healthcare faster, safer and more accessible while keeping patients at the centre of every decision The inaugural edition of the HAI Conclave […]
Article by: IMT News Desk
Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026
News
July 10, 2026

Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026

Fischer Medical Ventures Limited (FMVL) has announced that its strategic partner, Nanyang Biologics, has achieved a major international milestone with its AI-powered molecular research platform, NYB.AI, being featured in the opening showcase at NVIDIA GTC Taiwan 2026, ahead of the keynote address by NVIDIA Founder and CEO Jensen Huang. The recognition places NYB.AI among a […]
Article by: IMT News Desk
Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs
News
July 10, 2026

Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs

Indian pharmaceutical companies are expected to report healthy revenue growth in the first quarter of FY27, but margins are likely to compress as sector profitability comes under pressure. In a recent preview note, Goldman Sachs said it anticipates around 185 basis points year-on-year margin decline for the sector in the June quarter, driven primarily by […]
Article by: IMT News Desk
Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue
News
July 10, 2026

Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue

Dr Reddy’s Laboratories has announced a delay in commercial supplies of its semaglutide product after certain batches were found to be out of specification due to an issue with the active pharmaceutical ingredient (API) used in the drug. The company said it has initiated an investigation into the root cause and is taking corrective measures […]
Article by: IMT News Desk